142 related articles for article (PubMed ID: 6328512)
21. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
Witter RL; Bacon LD; Calvert JG
Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
[TBL] [Abstract][Full Text] [Related]
22. Identification of the cross-reactive antigens between Marek's disease virus and pseudorabies virus by monoclonal antibodies.
Nakajima K; Kweon CH; An SH; Shibayama T; Wakamiya N; Kato S; Hirai K
Avian Dis; 1990; 34(2):479-84. PubMed ID: 2164393
[TBL] [Abstract][Full Text] [Related]
23. Avian herpesvirus as a live viral vector for the expression of heterologous antigens.
Sondermeijer PJ; Claessens JA; Jenniskens PE; Mockett AP; Thijssen RA; Willemse MJ; Morgan RW
Vaccine; 1993; 11(3):349-58. PubMed ID: 8383385
[TBL] [Abstract][Full Text] [Related]
24. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
[TBL] [Abstract][Full Text] [Related]
25. Marek's disease--the disease and its prevention by vaccination.
Biggs PM
Br J Cancer Suppl; 1975 Mar; 2():152-5. PubMed ID: 170953
[TBL] [Abstract][Full Text] [Related]
26. The genome of herpesvirus of turkeys: comparative analysis with Marek's disease viruses.
Kingham BF; Zelnık V; Kopáček J; Majerčiak V; Ney E; Schmidt CJ
J Gen Virol; 2001 May; 82(Pt 5):1123-1135. PubMed ID: 11297687
[TBL] [Abstract][Full Text] [Related]
27. Studies on the serological cross-reaction between Marek's disease virus and herpesvirus of turkeys using monoclonal antibodies to major virus-specific polypeptides. Brief report.
Ikuta K; Nakajima K; Ueda S; Kato S; Hirai K
Arch Virol; 1984; 81(3-4):337-43. PubMed ID: 6206826
[TBL] [Abstract][Full Text] [Related]
28. The complete sequence and gene organization of the short unique region of herpesvirus of turkeys.
Zelník V; Darteil R; Audonnet JC; Smith GD; Riviere M; Pastorek J; Ross LJ
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2151-62. PubMed ID: 8409940
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the biological properties of type 2 plaque-producing agent derived from the Cal-1 strain of Marek's disease virus with other related viruses.
Kirisawa R; Hirai K; Yachida S; Kawakami Y; Kato S; Mikami T
Arch Virol; 1986; 89(1-4):29-43. PubMed ID: 3013131
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge.
Islam AF; Wong CW; Walkden-Brown SW; Colditz IG; Arzey KE; Groves PJ
Avian Pathol; 2002 Oct; 31(5):449-61. PubMed ID: 12427339
[TBL] [Abstract][Full Text] [Related]
31. Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek's disease.
Witter RL; Sharma JM; Offenbecker L
Avian Dis; 1976; 20(4):676-92. PubMed ID: 186008
[TBL] [Abstract][Full Text] [Related]
32. Marek's disease and new approaches to its control.
Zelník V
Acta Virol; 1995 Feb; 39(1):53-63. PubMed ID: 7572471
[TBL] [Abstract][Full Text] [Related]
33. The interplay between MDV and HVT affects viral miRNa expression.
Goher M; Hicks JA; Liu HC
Avian Dis; 2013 Jun; 57(2 Suppl):372-9. PubMed ID: 23901749
[TBL] [Abstract][Full Text] [Related]
34. Most virus-specific polypeptides in cells productively infected with Marek's disease virus or herpesvirus of turkeys possess cross-reactive determinants.
Ikuta K; Ueda S; Kato S; Hirai K
J Gen Virol; 1983 Apr; 64 (Pt 4)():961-5. PubMed ID: 6187896
[TBL] [Abstract][Full Text] [Related]
35. Marek's disease in turkeys. II. Characterization of the viral glycoprotein B gene and antigen of a turkey strain of Marek's disease virus.
Davidson I; Malkinson M; Weisman Y
Avian Dis; 2002; 46(2):322-33. PubMed ID: 12061641
[TBL] [Abstract][Full Text] [Related]
36. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
[TBL] [Abstract][Full Text] [Related]
37. Map location of homologous regions between Marek's disease virus and herpesvirus of turkey and the absence of detectable homology in the putative tumor-inducing gene.
Fukuchi K; Sudo M; Tanaka A; Nonoyama M
J Virol; 1985 Mar; 53(3):994-7. PubMed ID: 2983105
[TBL] [Abstract][Full Text] [Related]
38. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
Nazerian K; Witter RL; Lee LF; Yanagida N
Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies reactive with the surface and secreted glycoproteins of Marek's disease virus and herpesvirus of turkeys.
Ikuta K; Ueda S; Kato S; Hirai K
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2597-610. PubMed ID: 6198439
[TBL] [Abstract][Full Text] [Related]
40. Transfection studies in vitro and in vivo with isolated Marek's disease virus DNA.
Kaaden OR
IARC Sci Publ (1971); 1978; (24 Pt 2):627-33. PubMed ID: 221387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
